Global Pharmacokinetics Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Pharmacokinetics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Pharmacokinetics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Noncompartmental Methods
  • 1.4.3 Compartmental Methods
• 1.5 Market by Application
  • 1.5.1 Global Pharmacokinetics Market Share by Application: 2020 VS 2026
  • 1.5.2 Oncology
  • 1.5.3 Cardiovascular Diseases
  • 1.5.4 Infectious Diseases
  • 1.5.5 Autoimmune Diseases
  • 1.5.6 Respiratory Disorders
  • 1.5.7 Neurological Disorders
  • 1.5.8 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmacokinetics Market Perspective (2015-2026)
• 2.2 Global Pharmacokinetics Growth Trends by Regions
  • 2.2.1 Pharmacokinetics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmacokinetics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmacokinetics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Pharmacokinetics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Pharmacokinetics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmacokinetics Players by Market Size
  • 3.1.1 Global Top Pharmacokinetics Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmacokinetics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Pharmacokinetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Pharmacokinetics Market Concentration Ratio
  • 3.2.1 Global Pharmacokinetics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Revenue in 2019
• 3.3 Pharmacokinetics Key Players Head office and Area Served
• 3.4 Key Players Pharmacokinetics Product Solution and Service
• 3.5 Date of Enter into Pharmacokinetics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Pharmacokinetics Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmacokinetics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Pharmacokinetics Market Size by Application (2015-2020)
• 5.2 Global Pharmacokinetics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmacokinetics Market Size (2015-2020)
• 6.2 Pharmacokinetics Key Players in North America (2019-2020)
• 6.3 North America Pharmacokinetics Market Size by Type (2015-2020)
• 6.4 North America Pharmacokinetics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Pharmacokinetics Market Size (2015-2020)
• 7.2 Pharmacokinetics Key Players in Europe (2019-2020)
• 7.3 Europe Pharmacokinetics Market Size by Type (2015-2020)
• 7.4 Europe Pharmacokinetics Market Size by Application (2015-2020)

8 China

• 8.1 China Pharmacokinetics Market Size (2015-2020)
• 8.2 Pharmacokinetics Key Players in China (2019-2020)
• 8.3 China Pharmacokinetics Market Size by Type (2015-2020)
• 8.4 China Pharmacokinetics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Pharmacokinetics Market Size (2015-2020)
• 9.2 Pharmacokinetics Key Players in Japan (2019-2020)
• 9.3 Japan Pharmacokinetics Market Size by Type (2015-2020)
• 9.4 Japan Pharmacokinetics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Pharmacokinetics Market Size (2015-2020)
• 10.2 Pharmacokinetics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Pharmacokinetics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Pharmacokinetics Market Size by Application (2015-2020)

11 India

• 11.1 India Pharmacokinetics Market Size (2015-2020)
• 11.2 Pharmacokinetics Key Players in India (2019-2020)
• 11.3 India Pharmacokinetics Market Size by Type (2015-2020)
• 11.4 India Pharmacokinetics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Pharmacokinetics Market Size (2015-2020)
• 12.2 Pharmacokinetics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Pharmacokinetics Market Size by Type (2015-2020)
• 12.4 Central & South America Pharmacokinetics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Charles River Laboratories
  • 13.1.1 Charles River Laboratories Company Details
  • 13.1.2 Charles River Laboratories Business Overview
  • 13.1.3 Charles River Laboratories Pharmacokinetics Introduction
  • 13.1.4 Charles River Laboratories Revenue in Pharmacokinetics Business (2015-2020))
  • 13.1.5 Charles River Laboratories Recent Development
• 13.2 Covance
  • 13.2.1 Covance Company Details
  • 13.2.2 Covance Business Overview
  • 13.2.3 Covance Pharmacokinetics Introduction
  • 13.2.4 Covance Revenue in Pharmacokinetics Business (2015-2020)
  • 13.2.5 Covance Recent Development
• 13.3 Cyprotex
  • 13.3.1 Cyprotex Company Details
  • 13.3.2 Cyprotex Business Overview
  • 13.3.3 Cyprotex Pharmacokinetics Introduction
  • 13.3.4 Cyprotex Revenue in Pharmacokinetics Business (2015-2020)
  • 13.3.5 Cyprotex Recent Development
• 13.4 Drumetix Laboratories
  • 13.4.1 Drumetix Laboratories Company Details
  • 13.4.2 Drumetix Laboratories Business Overview
  • 13.4.3 Drumetix Laboratories Pharmacokinetics Introduction
  • 13.4.4 Drumetix Laboratories Revenue in Pharmacokinetics Business (2015-2020)
  • 13.4.5 Drumetix Laboratories Recent Development
• 13.5 Eurofins Scientific
  • 13.5.1 Eurofins Scientific Company Details
  • 13.5.2 Eurofins Scientific Business Overview
  • 13.5.3 Eurofins Scientific Pharmacokinetics Introduction
  • 13.5.4 Eurofins Scientific Revenue in Pharmacokinetics Business (2015-2020)
  • 13.5.5 Eurofins Scientific Recent Development
• 13.6 GVK Biosciences
  • 13.6.1 GVK Biosciences Company Details
  • 13.6.2 GVK Biosciences Business Overview
  • 13.6.3 GVK Biosciences Pharmacokinetics Introduction
  • 13.6.4 GVK Biosciences Revenue in Pharmacokinetics Business (2015-2020)
  • 13.6.5 GVK Biosciences Recent Development
• 13.7 LGC
  • 13.7.1 LGC Company Details
  • 13.7.2 LGC Business Overview
  • 13.7.3 LGC Pharmacokinetics Introduction
  • 13.7.4 LGC Revenue in Pharmacokinetics Business (2015-2020)
  • 13.7.5 LGC Recent Development
• 13.8 Parexel
  • 13.8.1 Parexel Company Details
  • 13.8.2 Parexel Business Overview
  • 13.8.3 Parexel Pharmacokinetics Introduction
  • 13.8.4 Parexel Revenue in Pharmacokinetics Business (2015-2020)
  • 13.8.5 Parexel Recent Development
• 13.9 Pharmoptima
  • 13.9.1 Pharmoptima Company Details
  • 13.9.2 Pharmoptima Business Overview
  • 13.9.3 Pharmoptima Pharmacokinetics Introduction
  • 13.9.4 Pharmoptima Revenue in Pharmacokinetics Business (2015-2020)
  • 13.9.5 Pharmoptima Recent Development
• 13.10 TCG Lifesciences
  • 13.10.1 TCG Lifesciences Company Details
  • 13.10.2 TCG Lifesciences Business Overview
  • 13.10.3 TCG Lifesciences Pharmacokinetics Introduction
  • 13.10.4 TCG Lifesciences Revenue in Pharmacokinetics Business (2015-2020)
  • 13.10.5 TCG Lifesciences Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer